Cite
HARVARD Citation
Cayssials, E. et al. (2020). Low‐dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment‐free remission in chronic myeloid leukemia patients: Results of a retrospective study. Cancer. 126 (15), pp. 3438-3447. [Online].